Troy D. Querec
YOU?
Author Swipe
View article: Clinical effectiveness of HPV vaccine by age at vaccination: a matched case-control study
Clinical effectiveness of HPV vaccine by age at vaccination: a matched case-control study Open
National Institutes of Health, American Cancer Society, Robert E. Leet and Clara Guthrie Patterson Trust, and Centers for Disease Control and Prevention.
View article: Comparison of Self-Collected Vaginal Swabs and First-Void Urine for Detection of Human Papillomavirus in Sexually Active Girls and Women in Three South Asian Countries
Comparison of Self-Collected Vaginal Swabs and First-Void Urine for Detection of Human Papillomavirus in Sexually Active Girls and Women in Three South Asian Countries Open
Background As more countries plan and launch human papillomavirus (HPV) vaccination campaigns, reliable self-sampling methods are essential for detecting high-risk HPV (HR-HPV) types and assessing public health impact. This study compared …
View article: Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022
Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022 Open
In 2006, human papillomavirus (HPV) vaccine was first recommended in the United States to prevent cancers and other diseases caused by HPV; vaccination coverage increased steadily through 2021, and increasing numbers of young women had rec…
View article: Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18–45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018–2023
Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18–45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018–2023 Open
Background We assessed human papillomavirus (HPV) vaccine effectiveness (VE) against anal HPV among men who have sex with men (MSM) in 2018–2023. Methods Residual anal specimens from MSM without HIV aged 18–45 years were tested for HPV. We…
View article: Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance Open
Monitoring the proportion of and reasons for failure to detect HPV in HSIL+ will help support high performance and quality improvement of HPV testing services. We encourage implementation of QA strategies based on re-analysis of "HPV negat…
View article: High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 Open
Human papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic disparities in cervical cancer incidence and mortality in the United States are well documented. HPV vaccination has been recommended in the United Stat…
View article: A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents
A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents Open
View article: Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study
Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study Open
View article: Data from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
Data from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Open
Animal models of ovarian cancer are crucial for understanding the pathogenesis of the disease and for testing new treatment strategies. A model of ovarian carcinogenesis in the rat was modified and improved to yield ovarian preneoplastic a…
View article: Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Open
Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
View article: Data from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
Data from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Open
Animal models of ovarian cancer are crucial for understanding the pathogenesis of the disease and for testing new treatment strategies. A model of ovarian carcinogenesis in the rat was modified and improved to yield ovarian preneoplastic a…
View article: Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Open
Supplementary Table 1-3 from Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
View article: Evaluation of the Novaplex II HPV28 Detection Assay for HPV Typing in Formalin-Fixed, Paraffin-Embedded Tissues
Evaluation of the Novaplex II HPV28 Detection Assay for HPV Typing in Formalin-Fixed, Paraffin-Embedded Tissues Open
View article: Human Papillomavirus Negative High Grade Cervical Lesions and Cancers: Suggested Guidance for Hpv Testing Quality Assurance
Human Papillomavirus Negative High Grade Cervical Lesions and Cancers: Suggested Guidance for Hpv Testing Quality Assurance Open
View article: Human Papillomavirus Detection in Scrotal Squamous Cell Carcinoma: Case Series from a Population-Based Cancer Registry.
Human Papillomavirus Detection in Scrotal Squamous Cell Carcinoma: Case Series from a Population-Based Cancer Registry. Open
The presence of HPV16 and p16 overexpression in the examined tissue specimens lends additional support for the role of HPV in the etiology of scrotal SCC.
View article: Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018 Open
Centers for Disease Control and Prevention.
View article: HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring Open
View article: 826. HIV Infection and HPV Genotype Patterns among Young Women with Advanced Cervical Neoplasia in Davidson County, Tennessee
826. HIV Infection and HPV Genotype Patterns among Young Women with Advanced Cervical Neoplasia in Davidson County, Tennessee Open
Background Women living with HIV (WLWH) experience high rates of human papillomavirus (HPV) infection and increased risk of cervical cancer. High-risk HPV (HR-HPV) types 16/18 cause most cervical precancers and cancers in women with and wi…
View article: Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women
Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women Open
ClinicalTrials.gov Identifier: NCT01298596.
View article: Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women
Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women Open
Background In the United States, human papillomavirus (HPV) vaccination has been recommended since 2011 for boys aged 11–12 years, with catch-up vaccination recommended through age 26 years for previously unvaccinated men who have sex with…
View article: Prevalence of human papillomavirus genotypes in high‐grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States
Prevalence of human papillomavirus genotypes in high‐grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States Open
Background US population‐based cancer registries can be used for surveillance of human papillomavirus (HPV) types found in HPV‐associated cancers. Using this framework, HPV prevalence among high‐grade cervical precancers and invasive cervi…
View article: Sexual Positioning Practices and Anal Human Papillomavirus Infection Among Young Men Who Have Sex with Men and Transgender Women—Chicago, Illinois, 2016–2018
Sexual Positioning Practices and Anal Human Papillomavirus Infection Among Young Men Who Have Sex with Men and Transgender Women—Chicago, Illinois, 2016–2018 Open
Background Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States; men who have sex with men (MSM) have higher prevalence of infection and related disease compared with other men. We assessed whet…
View article: Evaluation of natural killer cell assay performance on shipped blood specimens
Evaluation of natural killer cell assay performance on shipped blood specimens Open
View article: Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 Open
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States (1). Although most infections resolve without clinical sequalae, persistent HPV infection can cause cervical, other anogenital, and oropharyn…
View article: Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types—2015–2020
Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types—2015–2020 Open
Background Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare disease characterized by the growth of papillomas in the respiratory tract. In the United States, JORRP is not a nationally notifiable condition and current d…
View article: Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States
Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States Open
Introduction Human papillomavirus (HPV) can cause anogenital warts and several types of cancer, including cervical cancers and precancers. We estimated the prevalence, incidence, and number of persons with prevalent and incident HPV infect…
View article: Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018
Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men—United States, 2016–2018 Open
Background In the United States, human papillomavirus (HPV) vaccination has been recommended for young adult men who have sex with men (MSM) since 2011. Methods The Vaccine Impact in Men study surveyed MSM and transgender women aged 18–26 …
View article: An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues
An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues Open
View article: Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18 Open
Before 2016, human papillomavirus (HPV) vaccination was recommended on a 3-dose schedule. However, many vaccine-eligible US females received fewer than 3 doses, which provided an opportunity to evaluate the real-world vaccine effectiveness…
View article: Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses
Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses Open
Background Highly effective human papillomavirus (HPV) vaccines are used in many national programs in 3- or 2-dose schedules. We examined HPV vaccine effectiveness against HPV prevalence by number of doses. Methods We collected residual li…